
Not so long ago, if a doctor needed to know what was happening inside your body, the options were limited — a basic X-ray, an exploratory surgery, or educated guesswork. Today, a radiologist can map your brain’s blood vessels, detect a cancer smaller than a pea, or watch your heart metabolizing sugar in near real time — all without making a single incision.
The first medical X-ray appeared in 1895. For decades, imaging largely meant detecting fractures or large abnormalities. Today, radiology guides emergency care, cancer treatment, stroke therapy, cardiac management, and preventive medicine. Modern diagnostic imaging has transformed medicine in ways that would have seemed like science fiction to physicians just a few generations ago.
Modern imaging falls into three broad categories: structural imaging — what tissues look like, vascular imaging — how blood flows, and functional imaging — how cells behave metabolically. Here’s a plain-language guide to the big three: MRI/MRA, CT/CTA, and PET scans — what they are, how they work, and why they matter.
MRI and MRA: Magnets and Radio Waves
The MRI — magnetic resonance imaging — is one of the most versatile tools in modern medicine, and it works without a single ray of radiation. An MRI passes an electric current through coiled wires to create a temporary magnetic field in your body. A transmitter and receiver then send and receive radio waves, and a computer uses those signals to construct detailed digital images of whatever area is being scanned. Think of it as a very sophisticated tuning fork: it causes hydrogen atoms in your body’s water molecules to briefly align, then releases them — and the energy they emit on the way back creates the image. Because different tissues relax at different rates, MRI can distinguish gray matter from white matter in the brain, normal from inflamed or cancerous tissue, and ligament from muscle with impressive contrast.
The result is exceptional detail, especially for soft tissue. MRI scans take much clearer pictures of your brain, spinal cord, nerves, muscles, ligaments, and tendons than regular X-rays and CT scans. That’s why your orthopedic surgeon orders one when your knee goes sideways, and why neurologists reach for it when they suspect a stroke or multiple sclerosis.
MRA — magnetic resonance angiography — is MRI’s cousin, using the same magnetic technology but focused specifically on blood vessels. It lets physicians map arteries and veins in remarkable detail, identifying narrowing (stenosis), bulges (aneurysms), or blockages (occlusions) without the need for invasive catheterization. If your doctor suspects a blockage in the blood vessels feeding your brain or kidneys, an MRA can reveal it clearly. A contrast dye is sometimes injected to make vessels stand out even more sharply.
The main trade-offs with MRI are time and noise — scans generally take between 30 to 50 minutes, and the machine produces the kind of clanging racket that makes earplugs standard issue. People with certain metal implants or severe claustrophobia can’t always use it, which is where CT steps in.
CT and CTA: X-Rays, Upgraded
The CT scan — computed tomography — takes the familiar chest X-ray and turns it into something far more powerful. A CT scan takes multiple X-ray images from different angles rotating around the body, separates them by depth then processes them by computer to create cross-sectional views — essentially a detailed 3D picture rather than a flat 2D image. Think of slicing a loaf of bread: instead of seeing only the crust, you can examine every slice.
A CT shows more detail than a standard X-ray and is used to diagnose cancer, heart disease, injuries from trauma, and musculoskeletal disorders — it’s one of the most common imaging tests used today. Emergency departments rely on CT heavily because it’s fast, often completed in 10 to 15 minutes, and can quickly identify life-threatening conditions like internal bleeding or pulmonary embolism.
CTA — CT angiography — adds an injected contrast dye to the mix, allowing physicians to see blood vessels with high clarity. Contrasting agents help show various structures of the body more clearly, making CTA the go-to test for evaluating coronary arteries, aortic aneurysms, and vascular disease throughout the body. Unlike MRA, it’s faster and more widely available, though it does involve a dose of radiation — something physicians weigh carefully against the diagnostic benefit.
PET Scan: When Function Matters More Than Form
If MRI and CT show you the structure of the body, the PET scan — positron emission tomography — shows you what’s happening inside it. This is a fundamentally different question, and the technology reflects that.
A PET scan is used to see metabolism and chemical activity within your body. It can detect abnormal changes before structural changes occur — meaning it can detect cancer before a tumor is large enough to be seen on a CT or MRI. That’s a remarkable capability. The scan works by injecting a small amount of a radioactive tracer — most commonly a form of glucose — into your bloodstream. Diseased cells, particularly cancer cells, absorb more of the radiotracer than healthy ones do. Active cells consume glucose. Cancer cells, inflamed tissue, and active brain regions often use more glucose than surrounding tissue. These are called “hot spots,” and the PET scanner detects this radiation to produce images of affected tissue.
Beyond cancer, PET scans are invaluable in cardiology — showing whether heart muscle is still alive after a heart attack — and in neurology, helping diagnose Alzheimer’s disease, epilepsy, and brain tumors by revealing abnormal patterns of brain activity.
The trade-off is resolution. The image resolution of nuclear medicine images may not be as high as that of CT or MRI, which is why PET is rarely used alone today. Combined PET/CT scanners perform almost all PET scans today , marrying metabolic information with anatomical precision. Hybrid PET/MRI scanners are also emerging though not yet in widespread use. They are particularly valuable for soft-tissue cancers of the brain, liver, and pelvis.
How They Compare — and Why It Matters
The simplest way to think about these three technologies is this: CT shows shape and structure quickly, with emphasis on bone and dense tissue; MRI shows soft tissue in extraordinary detail without radiation; and PET shows function and cellular activity that neither of the others can see directly.
A patient with suspected cancer might undergo a CT scan to identify the location of a mass, followed by a PET to determine its metabolic activity, and then an MRI to map its relationship to critical soft tissues. Used together, these tools give physicians a picture of disease that is more complete than any single test could provide.
The value to modern medicine is difficult to overstate. These technologies allow doctors to diagnose conditions earlier, stage cancers more accurately, guide surgical planning, and monitor how well treatments are working — all without exploratory surgery. Survival rates for many cancers have improved substantially in part because imaging lets us find disease when it’s still manageable.
The era when medicine was largely guesswork about what lay beneath the skin is over. Today, radiologists are, in a very real sense, reading the body like an open book.
Illustration generated by author using ChatGPT.
Sources:
UNC Health Appalachian — MRI, CT, and PET Scan Comparison: https://www.unchealthappalachian.org/blog/2024/comparing-mri-ct-and-pet-scans-how-they-work-and-when-theyre-use/
WashU Mallinckrodt Institute of Radiology — Differences Between CT, MRI, and PET: https://www.mir.wustl.edu/do-you-know-the-differences-between-a-ct-mri-and-pet-scan/
Cleveland Clinic — PET Scan Overview: https://my.clevelandclinic.org/health/diagnostics/10123-pet-scan
RadiologyInfo.org — PET/CT: https://www.radiologyinfo.org/en/info/pet
Open MedScience — CT, MRI, and PET Differences: https://openmedscience.com/ct-mri-and-pet-scanners-unravelling-the-differences-in-modern-medical-imaging/
Healthline — MRI vs. PET Scan: https://www.healthline.com/health/mri-vs-pet-scan
Revere Health — MRI, CT, and PET Explained: https://reverehealth.com/live-better/mri-ct-pet/








America’s Healthcare Paradox: Why We Pay Double and Get Less
By John Turley
On January 5, 2026
In Commentary, Medicine
The healthcare debate in America often circles back to a fundamental question: should we move toward a single-payer system, or is our current mixed public-private model the better path forward? It’s a conversation that gets heated quickly, but when you strip away the politics and look at how different systems actually function around the world, some interesting patterns emerge.
What We Mean by Single-Payer
A single-payer healthcare system means that one entity—usually the government or a government-related organization—pays for all covered healthcare services. Doctors and hospitals can still be private (and usually are), but instead of dealing with dozens of different insurance companies, they bill one source. It’s a lot like Medicare, which is why proponents often call it “Medicare-for-all”.
The key thing to understand is that single-payer isn’t necessarily the same as socialized medicine. In Canada’s system, for instance, the government pays the bills, but doctors are largely in the private sector and hospitals are controlled by private boards or regional health authorities rather than being part of the national government. Compare that to the UK’s National Health Service, where many hospitals and clinics are government-owned and many doctors are government employees.
America’s Current Patchwork
The United States operates what might charitably be called a “creative” approach to healthcare—a complex mix of employer-sponsored private insurance, government programs like Medicare, Medicaid and the VA system, individual marketplace plans, and direct out-of-pocket payments. Government already pays roughly half of total US health spending, but benefits, cost-sharing, and networks vary widely between plans, with little overall coordination. In 2023, private health insurance spending accounted for 30 percent of total national health expenditures, Medicare covered 21 percent, and Medicaid covered 18 percent. Most of the remainder was either paid out of pocket by private citizens or was written off by providers as uncollectible.
Here’s where it gets expensive. U.S. health care spending grew 7.5 percent in 2023, reaching $4.9 trillion or $14,570 per person, accounting for 17.6 percent of the nation’s GDP, and national health spending for 2024 is expected to have exceeded $5.3 trillion or 18% of GDP, and health spending is expected to grow to 20.3 percent of GDP by 2033.
For a typical American family, the costs are real and rising. In 2024, the estimated cost of healthcare for a family of four in an employer-sponsored health plan was $32,066.
The European Landscape
Europe doesn’t have one healthcare model—it has several, and they’re all quite different from what we have in the States. Most of the 35 countries in the European Union have single-payer healthcare systems, but the details vary considerably.
Countries like the UK, Sweden, and Norway operate what are essentially single-payer systems where it is solely the government who pays for and provides healthcare services and directly owns most facilities and employs most clinical and related staff with funds from tax contributions. Then you have countries like Germany, and Belgium that use “sickness funds”—these are non-profit funds that don’t market, cherry pick patients, set premiums or rates paid to providers, determine benefits, earn profits or have investors. They’re quasi-public institutions, not private insurance companies like we know them in America. Some systems, such as the Netherlands or Switzerland, rely on mandatory individually purchased private insurance with tight regulation and subsidies, achieving universal coverage with a structured, competitive market.
The French System
France is particularly noted for a successful universal, government-run health insurance system usually described as a single-payer with supplements. All legal residents are automatically covered through the national health insurance program, which is funded by payroll taxes and general taxation.
Most physicians and hospitals are private or nonprofit, not government employees or facilities. Patients generally have free choice of doctors and specialists, though coordinating through a primary care physician improves access and reimbursement. The national insurer pays a large portion of medical costs (often 70–80%), while voluntary private supplemental insurance covers most remaining out-of-pocket expenses such as copays and deductibles.
France is known for spending significantly less per capita than the United States. Cost controls come from nationally negotiated fee schedules and drug pricing rather than limits on access.
What’s striking is that in 2019, US healthcare spending reached $11,072 per person—over double the average of $5,505 across wealthy European nations. Yet despite spending roughly twice as much per person, American health outcomes often lag behind.
The Outcomes Question
This is where the comparison gets uncomfortable for American exceptionalism. The U.S. has the lowest life expectancy at birth among comparable wealthy nations, the highest death rates for avoidable or treatable conditions, and the highest maternal and infant mortality.
In 2023, life expectancy in comparable countries was 82.5 years, which is 4.1 years longer than in the U.S. Japan manages this with healthcare spending at just $5,300 per capita, while Americans spend more than double that amount.
Now, it’s important to note that healthcare systems don’t operate in a vacuum. Life expectancy is influenced by many factors beyond medical care—diet, exercise, smoking, gun violence, drug overdoses, and social determinants of health all play roles. But when you’re spending twice as much and getting worse results, it suggests the system itself might be part of the problem.
Advantages of Single-Payer Systems
The case for single-payer rests on several compelling points. First, administrative simplicity translates to real cost savings. A study found that the administrative burden of health care in the United States was 27 percent of all national health expenditures, with the excess administrative cost of the private insurer system estimated at about $471 billion in 2012 compared to a single-payer system like Canada’s. That’s over $1 out of every $5 of total healthcare spending just going to paperwork, billing disputes, and insurance company profit and overhead before any patient receives care.
Universal coverage is another major advantage. In a properly functioning single-payer system, nobody goes bankrupt from medical bills, nobody delays care because they can’t afford it, and nobody loses coverage when they lose their job. The peace of mind that comes with knowing you’re covered regardless of employment status or pre-existing conditions is difficult to quantify but enormously valuable.
Single-payer systems also have significant negotiating power. When one entity is buying drugs and services for an entire nation, pharmaceutical companies and medical device manufacturers have much less leverage to charge whatever they want. This helps explain why prescription drug prices in other countries are often a fraction of prices in the U.S.
Disadvantages and Trade-offs
The critics of single-payer systems aren’t wrong about everything. Wait times are a genuine concern in some systems. When prices and overall budgets are tightly controlled, some countries experience longer waits for selected elective surgeries, imaging, or specialty visits, especially if investment lags demand.
In 2024, Canadian patients experienced a median wait time of 30 weeks between specialty referral and first treatment, up from 27.2 weeks in 2023, with rural areas facing even longer delays. For procedures like elective orthopedic surgery, patients wait an average of 39 weeks in Canada.
However, it’s crucial to understand that wait times are not a result of the single-payer system itself but of system management, as wait times vary significantly across different single-payer and social insurance systems. Many European countries with universal coverage don’t experience the same wait time issues that plague Canada.
The transition costs are also substantial. Moving from our current system to single-payer would disrupt a massive industry. Over fifteen percent of our economy is related to health care, with half spent by the private sector. Around 160 million Americans currently have insurance through their employers, and transitioning all of them to a government-run plan would be an enormous administrative and political challenge.
A large national payer can be slower to change benefit designs or adopt new payment models; shifting political majorities can affect funding levels and benefit generosity.
Taxes would need to increase significantly to fund such a system, though proponents argue this would be offset by the elimination of insurance premiums, deductibles, and co-pays. It’s essentially a question of whether you’d rather pay through taxes or through premiums—the money has to come from somewhere.
Advantages of America’s Mixed System
Our current system does have some genuine strengths. Innovation thrives in the American healthcare market. The profit motive, for all its flaws, does drive pharmaceutical research and medical device development. American medical schools and research institutions lead the world in many areas of medicine. Academic medical centers and specialty hospitals deliver advanced procedures and complex care that attract patients internationally.
The system also offers more choice for those who can afford it. If you have good insurance, you typically face shorter wait times for elective procedures and can often see specialists without lengthy delays. Americans with high-quality employer-sponsored coverage give their plans relatively high ratings.
Competition between providers can theoretically drive quality improvements, though this effect is often undermined by the complexity of the market and the difficulty consumers face in shopping for healthcare.
Disadvantages of the Current U.S. System
The most glaring problem is simple: The United States remains the only developed country without universal healthcare, and 30 million Americans remain uninsured despite gains under the Affordable Care Act, and many of these gains will soon be lost. Being uninsured in America isn’t just an inconvenience—it can be deadly. People delay care, skip medications, and avoid preventive screenings because of cost concerns.
The administrative complexity is staggering. Doctors spend enormous amounts of time dealing with insurance companies, prior authorizations, and billing disputes. Hospitals employ armies of billing specialists just to navigate the maze of different insurance plans, each with its own rules, formularies, and coverage determinations. U.S. administrative costs account for ~25% of all healthcare spending, among the highest in the world.
Medical bankruptcy is uniquely American. Even people with insurance can find themselves financially devastated by serious illness. High deductibles, surprise bills, and out-of-network charges create a minefield of potential financial catastrophe. Studies of U.S. bankruptcy filings over the past two decades have consistently found that medical bills and medical problems are a major factor in a large share of consumer bankruptcies. Recent summaries suggest that roughly two‑thirds of US personal bankruptcies involve medical expenses or illness-related income loss, and around 17% of adults with health care debt report declaring bankruptcy or losing a home because of that debt.
The system is also profoundly inequitable. Quality of care often depends more on your job, your income, and your zip code than on your medical needs. Out-of-pocket costs per capita have increased as compared to previous decades and the burden falls disproportionately on those least able to afford it.
What Europe Shows Us
The European experience demonstrates that there isn’t one “right” way to achieve universal coverage. The UK’s NHS, Germany’s sickness funds, and France’s hybrid system all manage to cover everyone at roughly half the per-capita cost of American healthcare. Universal Health Coverage exists in all European countries, with healthcare financing almost universally government managed, either directly through taxation or semi-directly through mandated and government-subsidized social health insurance.
They’ve accomplished this through various combinations of centralized negotiation of drug prices, global budgets for hospitals, strong primary care systems that serve as gatekeepers to more expensive specialist care, emphasis on preventive services, and regulation that prevents insurance companies from cherry-picking healthy patients.
Are these systems perfect? No. One of the major disadvantages of centralized healthcare systems is long wait lists to access non-urgent care, though Americans often wait as long or longer for routine primary care appointments as do patients in most universal-coverage countries. Many European countries are wrestling with funding challenges as populations age and expensive new treatments become available. But they’ve solved the fundamental problem that America hasn’t: they ensure everyone has access to healthcare without the risk of financial ruin.
The Path Forward?
The debate over healthcare in America often presents false choices. We don’t have to choose between Canadian-style single-payer and our current system—there are multiple models we could adapt. We could move toward a German-style system with heavily regulated non-profit insurers. We could create a robust public option that competes with private insurance. We could expand Medicare gradually by lowering the eligibility age over time.
What’s clear from international comparisons is that the status quo is unusually expensive and produces mediocre results. We’re paying premium prices for economy outcomes. Whether single-payer is the answer depends partly on your priorities. Do you value universal coverage and cost control more than unlimited choice? Are you willing to accept potentially longer wait times for non-urgent care in exchange for lower costs and universal access? How much do you trust government to manage a program this large?
These aren’t easy questions, and reasonable people disagree. But the evidence from Europe suggests that universal coverage at reasonable cost is achievable—it just requires us to make some choices about what we value most in a healthcare system.
Sources: